Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -17.99%354.8M | -24.24%234.27M | -30.97%113.39M | -3.45%579.26M | 4.71%432.65M | 18.57%309.24M | 47.60%164.26M | 21.94%599.98M | 11.50%413.19M | 3.64%260.81M |
| Refunds of taxes and levies | -66.38%40.2K | -66.24%15.39K | ---- | -99.56%5.15K | -89.79%119.59K | 16.26%45.59K | --12.45K | -95.39%1.17M | -95.40%1.17M | -99.85%39.21K |
| Cash received relating to other operating activities | 46.97%40.19M | -10.94%12.32M | -27.38%11.01M | 83.63%35.15M | 77.89%27.35M | 62.74%13.84M | 36.25%15.16M | -37.58%19.14M | -62.58%15.37M | -47.06%8.5M |
| Cash inflows from operating activities | -14.15%395.03M | -23.68%246.61M | -30.67%124.4M | -0.95%614.41M | 7.07%460.12M | 19.96%323.12M | 46.58%179.44M | 13.16%620.29M | -1.68%429.74M | -8.12%269.35M |
| Goods services cash paid | -26.01%193.23M | -30.64%127.66M | -14.63%66.23M | -32.03%315M | -25.90%261.17M | -17.84%184.05M | 23.07%77.58M | 60.77%463.41M | 63.07%352.46M | 73.14%224.03M |
| Staff behalf paid | -9.23%57.23M | -0.17%39.41M | 28.14%21.36M | 10.33%83.78M | 17.11%63.05M | 16.61%39.48M | 5.11%16.67M | 8.78%75.93M | 9.18%53.84M | -0.43%33.86M |
| All taxes paid | -32.29%25.42M | -45.70%16.41M | -65.20%7.09M | 29.67%42.64M | 50.88%37.54M | 75.15%30.22M | 159.51%20.39M | 146.64%32.88M | 179.58%24.88M | 259.36%17.25M |
| Cash paid relating to other operating activities | -3.75%128.39M | -4.15%80.2M | -17.76%46.28M | 12.90%135.7M | 36.43%133.4M | 13.03%83.67M | 29.75%56.28M | -4.84%120.19M | -15.52%97.78M | -2.24%74.02M |
| Cash outflows from operating activities | -18.35%404.27M | -21.85%263.68M | -17.52%140.97M | -16.65%577.12M | -6.39%495.16M | -3.36%337.42M | 31.34%170.91M | 39.12%692.42M | 35.60%528.96M | 43.15%349.16M |
| Net cash flows from operating activities | 73.63%-9.24M | -19.36%-17.07M | -294.43%-16.57M | 151.70%37.29M | 64.69%-35.04M | 82.08%-14.3M | 210.46%8.52M | -243.03%-72.13M | -311.27%-99.23M | -262.12%-79.81M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -86.67%5.38M | -86.67%5.38M | -99.78%45K | -28.31%56.03M | 108.19%40.37M | 133.14%40.37M | 566.67%20M | -80.20%78.15M | -94.33%19.39M | -91.28%17.31M |
| Cash received from returns on investments | ---- | ---- | ---- | 91.82%624.74K | -79.47%751.79K | -79.27%751.79K | ---- | -93.03%325.69K | -21.35%3.66M | 15.51%3.63M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.78%2K | 5.26%2K | 5.26%2K | 1,952.47%6.51M | 187.19%904.66K | -99.40%1.9K | -98.59%1.9K | 123.89%316.96K | 119.41%315K | 130.65%315K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | --3M | --3M | --368K | --982K | ---- | ---- |
| Cash received relating to other investing activities | -82.65%924.07K | -63.80%924.07K | 36.99%691.11K | ---- | -78.98%5.33M | -89.93%2.55M | --504.51K | 444.60%25.34M | 1,679.22%25.34M | 1,679.22%25.34M |
| Cash inflows from investing activities | -87.48%6.31M | -86.49%6.31M | -96.46%738.11K | -39.92%63.16M | 3.37%50.35M | 0.16%46.67M | 564.72%20.87M | -73.99%105.12M | -86.02%48.71M | -77.08%46.6M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -28.09%31.7M | -71.07%7.12M | -40.16%6.08M | -35.54%46.66M | -25.47%44.08M | -42.26%24.63M | -69.40%10.17M | -47.60%72.38M | -57.80%59.15M | -49.04%42.65M |
| Cash paid to acquire investments | ---- | ---- | ---- | -61.87%30.01M | 60.79%35.98M | -10.63%20M | ---- | -74.39%78.71M | -91.21%22.38M | -90.40%22.38M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --3.01M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | --33.25M | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -72.03%31.7M | -84.04%7.12M | -40.16%6.08M | -47.26%79.68M | 38.99%113.32M | -31.38%44.63M | -89.53%10.17M | -66.24%151.09M | -79.35%81.53M | -79.48%65.03M |
| Adjustment items of net investing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- |
| Net cash flows from investing activities | 59.67%-25.39M | -139.95%-818.08K | -149.92%-5.35M | 64.05%-16.52M | -91.87%-62.96M | 111.11%2.05M | 111.39%10.71M | -5.91%-45.97M | 29.45%-32.82M | 83.77%-18.43M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | -85.19%12.12K | 119.19%179.4K | ---- | ---- | --81.85K | --81.85K | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | -85.19%12.12K | ---- | ---- | ---- | --81.85K | --81.85K | ---- |
| Cash from borrowing | -18.68%276.04M | -11.15%246.47M | 22.53%70.23M | 2.48%330.64M | 9.93%339.43M | 0.83%277.38M | -67.54%57.32M | 60.61%322.65M | 64.96%308.76M | 111.90%275.09M |
| Cash received relating to other financing activities | -0.92%11.41M | ---- | -62.25%194.26K | 440.14%16.9M | 20,960.30%11.51M | --1.51M | -49.08%514.62K | -93.10%3.13M | --54.66K | ---- |
| Cash inflows from financing activities | -18.13%287.44M | -11.63%246.47M | 21.77%70.43M | 6.66%347.56M | 13.67%351.12M | 1.38%278.9M | -67.44%57.84M | 32.32%325.86M | 65.03%308.89M | 111.90%275.09M |
| Borrowing repayment | -14.67%238.03M | -12.10%197.69M | -71.50%34.35M | 62.73%371.87M | 83.45%278.96M | 73.97%224.89M | 65.08%120.5M | 34.93%228.52M | 67.28%152.06M | 122.64%129.27M |
| Dividend interest payment | 5.92%20.71M | 14.56%13.87M | 6.46%6.4M | -14.74%28.93M | -27.79%19.55M | -37.86%12.11M | 2.61%6.01M | 5.17%33.93M | 19.73%27.08M | 25.47%19.49M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.2M | ---- | ---- |
| Cash payments relating to other financing activities | 246.48%13.17M | 88.22%1.34M | 294.97%454.02K | 45.47%12.75M | -764.11%-8.99M | 76.78%711.27K | 24.86%114.95K | -76.34%8.77M | -73.18%1.35M | -92.03%402.36K |
| Cash outflows from financing activities | -6.08%271.92M | -10.44%212.9M | -67.47%41.2M | 52.48%413.55M | 60.40%289.52M | 59.37%237.72M | 60.40%126.62M | 13.63%271.22M | 52.23%180.5M | 89.66%149.16M |
| Net cash flows from financing activities | -74.79%15.53M | -18.49%33.57M | 142.50%29.23M | -220.76%-65.99M | -52.03%61.59M | -67.30%41.18M | -169.71%-68.79M | 619.89%54.65M | 87.15%128.4M | 146.07%125.93M |
| Net cash flow | ||||||||||
| Adjustment items effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- |
| Net increase in cash and cash equivalents | 47.52%-19.11M | -45.79%15.68M | 114.77%7.32M | 28.73%-45.22M | -898.40%-36.41M | 4.48%28.93M | -1,539.94%-49.56M | -533.83%-63.45M | -105.28%-3.65M | 310.19%27.69M |
| Add:Begin period cash and cash equivalents | -34.87%97.6M | -31.66%97.6M | -32.11%97.6M | -30.76%142.82M | -27.36%149.84M | -30.76%142.82M | -30.27%143.75M | 7.63%206.27M | 7.63%206.27M | 7.63%206.27M |
| End period cash equivalent | -30.80%78.49M | -34.04%113.28M | 11.38%104.92M | -31.66%97.6M | -44.02%113.44M | -26.59%171.75M | -53.63%94.2M | -30.76%142.82M | -22.28%202.63M | 31.09%233.96M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shanghui Accounting Firm (Special General Partnership) | -- | -- | -- | Shanghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.